Vinge Logotype
SvenskaEnglish 18D7E0DE-2035-40AE-A740-8F45A358A8F4 Login
  1. Home
  2. Mandates
  3. Vinge has advised Borgo AB in its a credit institution license application
Mandate

Vinge has advised Borgo AB in its a credit institution license application

March 17, 2021 Corporate Commercial Banking and Finance Insurance Law

Vinge has successfully advised Borgo AB in its license applications as a credit institution. The authorisation was granted by the Swedish FSA on 11 March 2021.

Borgo is an independent mortgage lending company aiming to offer market leading mortgages to Swedish consumers. Borgo’s mortgage products will be offered by ICA Banken, Ikano Bank, Söderberg & Partners and Ålandsbanken, under their brands but with Borgo as lender.

Vinge’s team consisted of, among others Johan Larsson (Corporate), Emma Stuart-Beck, Caroline Krassén and Mikaela Lang (Financial Services), Martin Boström (Commercial Agreements), Paulina Malmberg (Corporate Insurance) and Jolinn Uhlin (Banking & Finance).

Related

Vinge advises Egetis Therapeutics in connection with ANI Pharmaceuticals’ public cash offer

 On 5 November 2026, ANI Pharmaceuticals, Inc., a U.S. biopharmaceutical company listed on The Nasdaq Global Market, announced a recommended public cash offer to the shareholders of Egetis Therapeutics AB (publ) and to the holder of Egetis’ convertible loan and warrants to tender all shares, the convertible loan and the warrants in Egetis to ANI. The total value of the offer amounts to approximately SEK 5,304 million.
November 10, 2026

Vinge has advised Xspray Pharma in connection with its rights issue

 Vinge has advised Xspray Pharma AB (publ) in connection with a rights issue of approximately SEK 90 million before transaction costs, with an over-allotment issue of approximately SEK 72 million.
November 09, 2026

Vinge advises SenzaGen on its acquisition of Alcyomics

 SenzaGen AB (publ) has acquired Alcyomics Ltd. The transaction is being financed through a combination of existing cash and a directed issue of convertible bonds.
November 09, 2026